Infex Therapeutics
PrivateLast Round
VC Round
May 12, 2026
Total Funding Raised
$2.35M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Infex Therapeutics is a biotechnology company that acquires, develops, and licenses innovative drugs to treat pandemic and critical priority infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infex Therapeutics Comparables
Compare Infex Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VenatoRx Pharmaceuticals | 78% | |
| Centauri Therapeutics Limited | 77% | |
| Bioversys | 77% | |
Infex Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 12, 2026 | ||||
| Grant | Feb 17, 2025 | ||||
| Grant | Aug 8, 2022 | ||||
| VC Round | Mar 22, 2019 |
Infex Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| Innovate UK | Grant |
| LifeArc | VC Round |
| Catapult Ventures | VC Round |
| Catapult Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 7, representing 29% of headcount.
- May 12, 2026
$5.8M round led by Jon Moulton
Infex Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Infex Therapeutics's valuation, stock price, and market status.